TR200906322A2 - Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. - Google Patents

Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.

Info

Publication number
TR200906322A2
TR200906322A2 TR2009/06322A TR200906322A TR200906322A2 TR 200906322 A2 TR200906322 A2 TR 200906322A2 TR 2009/06322 A TR2009/06322 A TR 2009/06322A TR 200906322 A TR200906322 A TR 200906322A TR 200906322 A2 TR200906322 A2 TR 200906322A2
Authority
TR
Turkey
Prior art keywords
improved solubility
granules
stability properties
stability
properties
Prior art date
Application number
TR2009/06322A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/06322A priority Critical patent/TR200906322A2/tr
Priority to PCT/TR2010/000167 priority patent/WO2011034513A1/en
Priority to EP10801007A priority patent/EP2467129A1/en
Publication of TR200906322A2 publication Critical patent/TR200906322A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, tek başına veya HCTZ gibi bir terapotik ajanla kombinasyon halindeki ramiprili içeren çözünürlük ve stabilite özellikleri geliştirilmiş farmasötik bileşimlere, bu bileşimlerin hazırlanma yöntemine ve tıbbi kullanımına ilişkindir
TR2009/06322A 2009-08-17 2009-08-17 Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. TR200906322A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/06322A TR200906322A2 (tr) 2009-08-17 2009-08-17 Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
PCT/TR2010/000167 WO2011034513A1 (en) 2009-08-17 2010-08-13 The granules with improved solubility and stability
EP10801007A EP2467129A1 (en) 2009-08-17 2010-08-13 The granules with improved solubility and stability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/06322A TR200906322A2 (tr) 2009-08-17 2009-08-17 Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.

Publications (1)

Publication Number Publication Date
TR200906322A2 true TR200906322A2 (tr) 2011-07-21

Family

ID=43568838

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/06322A TR200906322A2 (tr) 2009-08-17 2009-08-17 Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.

Country Status (3)

Country Link
EP (1) EP2467129A1 (tr)
TR (1) TR200906322A2 (tr)
WO (1) WO2011034513A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163579B2 (en) * 2004-04-14 2007-01-16 H.B. Fuller Licensing & Financing Inc. Method of making water resistant corrugated boards

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025292A (en) 1962-03-13 Reduction of i
DE3226768A1 (de) 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
DE3739690A1 (de) 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
EP1083931B1 (en) 1998-06-05 2005-05-11 Warner-Lambert Company LLC Stabilization of compositions containing ace inhibitors using magnesium oxide
US20030225124A1 (en) 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
CA2357982A1 (en) 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
EA007981B1 (ru) 2002-01-15 2007-02-27 Актавис Груп Хф. Фармацевтический состав, содержащий хинаприл или фармацевтически приемлемую его соль
EP1467717A1 (en) 2002-01-15 2004-10-20 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
US20030215526A1 (en) 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
US20060177498A1 (en) 2003-01-22 2006-08-10 Ramaswami Bharatrajan Solid pharmaceutical composition comprising ramipril
CA2530788C (en) 2003-06-26 2010-02-09 Teva Pharmaceutical Industries Ltd Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
GB2404336A (en) 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
AU2003300692A1 (en) 2003-10-30 2005-05-19 Lupin Ltd. Stable formulations of ace inhibitors and methods for preparation thereof
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
WO2005067887A2 (en) 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
US20060045911A1 (en) 2004-08-27 2006-03-02 Sun Pharmaceutical Industries Ltd. Stable pharmaceutical formulations
WO2006052968A2 (en) 2004-11-05 2006-05-18 King Pharmaceuticals Research & Development, Inc. Stabilized ramipril compositions and methods of making
US20070116762A1 (en) 2005-11-07 2007-05-24 Wilson Edward S Compositions of stabilized ramipril in combination with another active agent
WO2008001184A2 (en) 2006-06-26 2008-01-03 Emcure Pharmaceuticals Limited Solid composition
AU2007264414A1 (en) 2006-06-30 2008-01-03 Alphapharm Pty Ltd A stabilised composition comprising ACE inhibitors
GB0624090D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
PL382311A1 (pl) 2007-04-27 2008-11-10 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Kompozycja farmaceutyczna o polepszonej stabilności zawierająca inhibitor acetylocholinoesterazy lub farmaceutycznie dopuszczalną jego sól oraz sposób jej wytwarzania
WO2008132756A1 (en) 2007-05-01 2008-11-06 Lupin Limited Stable pharmaceutical compositions of ramipril

Also Published As

Publication number Publication date
WO2011034513A1 (en) 2011-03-24
EP2467129A1 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
UA109010C2 (en) Morpholino pyrividines and their use in therapy
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
NZ595372A (en) Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
IN2012DN01233A (tr)
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
JO3366B1 (ar) مثبطات بيرازوليل كوينوكزالين كاينيز
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX2011009847A (es) Agentes antihelminticos y su uso.
PH12014500386A1 (en) Combination treatment for hepatitis c
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
UA109037C2 (uk) Триазолопіридини
MX2012005507A (es) Antagonistas de espiro-oxindol de mdm2.
TR200806298A2 (tr) Farmasötik formülasyon
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
MX342947B (es) Tratamiento de diabetes tipo 2.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
MX2015011614A (es) Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia.
GEP20135859B (en) Stable combined pharmaceutical composition
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.